|
2024
|
Invention
|
Variant asparaginase polypeptides for medical use.
Provided are various embodiments relating to ... |
|
2023
|
Invention
|
Anti-il31 antibodies for veterinary use.
Provided are various embodiments relating to anti-IL31 ... |
|
2021
|
Invention
|
Tnf alpha and ngf antibodies for veterinary use.
Provided are various embodiments relating to ca... |
|
|
Invention
|
Tnf alpha and ngf antibodies for veterinary use. Provided are various embodiments relating to can... |
|
|
Invention
|
Long-acting anti-il31 antibodies for veterinary use. Provided are various embodiments relating to... |
|
|
Invention
|
Il4/il13 receptor molecules for veterinary use. Provided are various embodiments relating to IL13... |
|
|
Invention
|
Anti-il4 receptor antibodies for veterinary use. Provided are various embodiments relating to ant... |
|
2020
|
Invention
|
Anti-il31 antibodies for veterinary use. Provided are various embodiments relating to anti-IL31 a... |
|
|
Invention
|
Parvovirus antibodies for veterinary use. Provided are various embodiments relating to parvovirus... |
|
|
Invention
|
Equine esomeprazole formulations and methods of use. The present disclosure relates to formulatio... |
|
|
Invention
|
Ngf antagonists for medical use. Provided are various embodiments relating to TrkA ECD polypeptid... |
|
2019
|
Invention
|
Igg fc variants for veterinary use.
Provided are various embodiments relating to variant IgG Fc ... |
|
|
Invention
|
Igg fc variants for veterinary use. Provided are various embodiments relating to variant IgG Fc p... |
|
|
Invention
|
Erythropoietin analogs for veterinary use. Provided are various embodiments relating to erythropo... |
|
|
Invention
|
Il4/il13 receptor molecule for veterinary use.
Provided are various embodiments relating to IL13... |
|
|
Invention
|
Il4/il13 receptor molecule for veterinary use. Provided are various embodiments relating to IL13R... |
|
|
Invention
|
Fc variants with altered binding to neonatal fc receptor (fcrn) for veterinary use. Provided are ... |
|
|
Invention
|
Variant asparaginase polypeptides for medical use. Provided are various embodiments relating to v... |
|
|
P/S
|
Veterinary preparations, namely, anti-inflammatory and/or antipyretic preparations |
|
2018
|
Invention
|
Il17a antibodies and antagonists for veterinary use. Provided are various embodiments relating to... |
|
|
Invention
|
Erythropoietin and analogs for veterinary use. Provided are various embodiments relating to felin... |
|
2016
|
P/S
|
Veterinary preparations for the treatment of atopic dermatitis, cancer, osteoarthritis, pain, sei... |
|
|
Invention
|
Compositions and methods for treatment and prevention of pyrexia in horses. Methods for treating ... |
|
|
Invention
|
Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats. P... |
|
2014
|
Invention
|
Treatment of pain in animals. Pharmaceutical formulations and unit dose forms useful for the trea... |
|
|
Invention
|
Treatment of atopic dermatitis in non-human animals. Atopic dermatitis and pruritus can be effica... |
|
2013
|
Invention
|
Methods for drug delivery.
Methods for delivering a drug to an animal while preventing or reduci... |
|
|
Invention
|
Vegf receptor fusion proteins for veterinary use. Companion animal vascular endothelial growth fa... |
